Age-related factors and co-morbidities increase elderly breast cancer patients' vulnerability to cardiotoxicity during cancer treatment. Lack of best practices and frailty bias in these patients, underrepresented in trials, may lead to inappropriate interventions and undertreatment, resulting in poorer outcomes, deterioration of quality of life and increased healthcare costs. The EU-funded CARDIOCARE project will focus on the elderly breast cancer population. Through a holistic approach including eHealth applications, wearable sensors and biomarkers it will enable patients to take part in their care process and enhance their physical and mental health, contributing to an individualised care plan and a psychological adaptation to their disease. CARDIOCARE will enable effective risk stratification, mitigating cardiotoxicity and adverse events, minimising hospitalisation and enhancing quality of life.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Complex Healthcare Challenges.
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://cardiocare-project.eu
Cardiocare Questions
Cardiocare's website is https://cardiocare-project.eu
Cardiocare's LinkedIn profile is https://www.linkedin.com/company/cardiocare-eu
Cardiocare has
6 employees.
View email and phone details for 6
employees at Cardiocare.
Cardiocare's industry is
Research Services
Cardiocare's top competitors are
Navarchos,
Save Electricity Solutions,
Cardiolife Aps,
Stremble Ventures Ltd,
Sunshadow Investments Ltd,
Research Group "child, Maternal And Family Health Care",
Cardio Life,
Startup Grind Cyprus,
Cardiocare Llc,
Escape.
Cardiocare's categories are Research Services
Cardiocare's founding year is 2021
